Form 8-K - Current report:
SEC Accession No. 0001193125-16-721558
Filing Date
2016-09-27
Accepted
2016-09-27 16:10:55
Documents
9
Period of Report
2016-09-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d269553d8k.htm 8-K 36180
2 EX-3.1 d269553dex31.htm EX-3.1 73417
3 EX-4.1 d269553dex41.htm EX-4.1 39661
4 EX-4.2 d269553dex42.htm EX-4.2 39427
5 EX-5.3 d269553dex53.htm EX-5.3 89297
6 EX-10.1 d269553dex101.htm EX-10.1 140665
7 EX-10.2 d269553dex102.htm EX-10.2 45489
8 EX-10.3 d269553dex103.htm EX-10.3 16829
9 EX-99.1 d269553dex991.htm EX-99.1 16781
  Complete submission text file 0001193125-16-721558.txt   499267
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 161904550
SIC: 2834 Pharmaceutical Preparations